Articles from 20/20 Onsite

20/20 Onsite, the leading provider of point-of-need ophthalmic services for clinical trials, announces the deployment of its latest mobile vision clinic, bringing its fleet to 16 units, including a mix of mobile clinics, pods, and suites. The new unit hit the road in early May and is now fully operational, enabling 20/20 Onsite to support a higher tempo of decentralized and hybrid clinical trials nationwide.

20/20 Onsite has been named a Silver Winner in the 2025 TITAN Health Awards in Provider & Services - Healthcare for Transforming Healthcare Through Patient-Centric, Point-of-Need Ophthalmic Assessments. This international honor recognizes 20/20 Onsite’s commitment to making healthcare more accessible and impactful through patient-centric, point-of-need ophthalmic solutions.

20/20 Onsite, a leader in delivering point-of-need ophthalmic assessments for clinical trials, is proud to announce its recognition with the Safety Excellence Award by Whip Around. This accolade underscores the company's unwavering commitment to operational excellence and safety in delivering point-of-need eye care services.

20/20 Onsite is proud to announce that two of its executives, Sonali Bloom, CEO, and Jessica McKenzie Mays, Vice President of Life Sciences, have been named 2024 Female Executives of the Year by the TITAN Women in Business Awards, presented by the International Awards Associate (IAA). Bloom received the Platinum Award for CEO of the Year, while McKenzie Mays was honored with the Platinum Award for Innovative Executive of the Year. These prestigious awards recognize their remarkable leadership and accomplishments in the business industry.

20/20 Onsite is proud to announce that, in collaboration with the American Diabetes Association® and Genentech, it will be on-site with its Mobile Vision Clinic to provide free diabetic eye screenings at the 2024 Step Out Walk to Stop Diabetes: DMV at The National Mall, 900 Jefferson Drive, SW, in Washington, DC, on Saturday, September 21, 2024 from 8:00am-2:00pm.

20/20 Onsite, a Boston-based mobile eye care company whose mission is to expand access to high-quality care, is partnering with Southbridge Public Schools, and the Health Foundation of Central Massachusetts to provide comprehensive eye exams and glasses to SPS students at no cost to their families.

20/20 Onsite, a leader in innovative mobile clinical vision solutions, proudly announces that all of its Life Sciences clinic managers are now Certified Paraoptometrics (CPOs) after a stringent examination process.

For the fourth consecutive year, 20/20 Onsite, the leading provider of on-site vision care, is partnering with Boston Public Schools, the New England College of Optometry, and Warby Parker to provide vision screenings, eye exams, and glasses to BPS children at no cost to their families.

20/20 Onsite, a Boston-based eye care company, proudly announces its recent achievement at the Massachusetts Innovation Network 2023 Eddies Awards. The company has been honored with the esteemed Eddies Award in the Healthy Living category for its innovative approach to addressing challenges in vision care accessibility and revolutionizing the landscape of clinical trials.

20/20 Onsite, Boston-based mobile optometry company, is excited to announce their expansion to Florida, now offering their leading on-site vision care services to Orlando employers.

20/20 Onsite, the leading provider of innovative mobile vision care solutions, becomes the first and only mobile clinic to earn a Site Readiness Certification from Precision Vision Clinical Trial Solutions, a division of Precision Vision. This certification gives study sponsors confidence that 20/20 Onsite possesses the required equipment and clinical staff to accurately perform and collect data to support their primary endpoints, such as best-corrected visual acuity (BCVA) testing.

20/20 Onsite, Boston Public Schools (BPS), the New England College of Optometry (NECO) , and Warby Parker continue their partnership with “Vision for Boston,” a program offering BPS students free, comprehensive eye examinations and corrective eyewear.

20/20 Onsite, a Boston-based mobile optometry company, has expanded its clinical research program with a one-of-a-kind delivery model to make clinical trials even more accessible for patients across the country. The model, called Mobile Vision Pods (MVP), utilizes a modular structure, making it an ideal solution for clinical researchers who need a temporary but full-service site to accommodate intense patient visit schedules.

20/20 Onsite, a mobile optometry and life sciences company, is pleased to announce the appointment of Sonali Bloom as the new Chief Executive Officer. Bloom is moving up from the role of VP of Product and Experience with a four-year tenure at the company. She is honored to lead and guide the team in its mission to make high-quality vision care more widely accessible.

20/20 Onsite, a Boston-based mobile eye health provider has launched three new Mobile Vision Clinics and updated its look to help fulfill its mission of providing high-quality, accessible vision care to patients across the country.